| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Mar 15, 2019 | Option Exercise | $15.45 | 252 | 3,893 | 6,898 | Mar 19, 2019, 08:58 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Mar 18, 2019 | Sale | $15.48 | 498 | 7,709 | 6,400 | Mar 19, 2019, 08:58 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Jan 22, 2019 | Sale | $15.56 | 1,250 | 19,450 | 4,625 | Jan 23, 2019, 09:38 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Jan 03, 2019 | Sale | $19.48 | 375 | 7,305 | 4,000 | Jan 04, 2019, 09:33 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Dec 31, 2018 | Option Exercise | $17.11 | 375 | 6,416 | 4,375 | Jan 02, 2019, 08:02 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 20, 2018 | Sale | $20.66 | 491 | 10,144 | 4,000 | Nov 21, 2018, 06:30 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 15, 2018 | Option Exercise | $20.99 | 259 | 5,436 | 4,491 | Nov 16, 2018, 06:17 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 09, 2018 | Sale | $18.53 | 4,376 | 81,109 | 6,938 | Nov 09, 2018, 08:59 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Financial Officer | Jul 06, 2018 | Sale | $28.35 | 393 | 11,142 | 4,750 | Jul 06, 2018, 09:17 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Financial Officer | Jun 29, 2018 | Option Exercise | $23.33 | 393 | 9,170 | 5,143 | Jul 03, 2018, 08:20 PM |
Menu